The 14th World Clinical Biomarkers & Companion Diagnostics Summit is the premier event for diagnostic stakeholders, bringing together over 500 senior leaders in the fields of biomarkers, translational medicine, and precision medicine. This year’s agenda offers enhanced networking opportunities, uniting drug developers, diagnostics providers, payers, and coalitions to exchange insights and accelerate biomarker-driven clinical trials. With a focus on early disease biomarker discovery, clinical biomarker strategy, reimbursement clarity, and drug-diagnostics commercialization, the summit is essential for those shaping the future of precision medicine and improving patient outcomes.
CEO Fernando Aguirre will be attending the 14th World Clinical Biomarkers & Companion Diagnostics Summit this September. If you’re interested in discussing the latest advancements in precision medicine or exploring collaboration opportunities, be sure to get in touch and arrange a meeting with him during the event.
This project has been co-funded by the European Union’s Horizon Europe research and innovation programme under grant agreement Nº101161495.
“Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.”
Stay connected
Subscribe to the HAWK Biosystems newsletter and don’t miss any news about our company, our products, events and much more.